AOD-9604
Modified HGH fragment 176-191 analog targeted at fat loss without GH side effects.
Metabolic effects build over days to weeks of consistent use.
Store the lyophilized powder refrigerated (2 to 8 C), or frozen for long-term storage, protected from light. After reconstitution with bacteriostatic water, keep refrigerated and use within about 4 weeks.
Clinical Evidence
What the literature says
Scientific Overview
AOD-9604 is the C-terminal fragment of HGH (residues 177–191) plus a tyrosine. Investigated for obesity in Phase 2 trials; TGA-listed as a complementary medicine in Australia.
Citations (4)
- Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormonePubMed
- Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragmentPubMed
- The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out micePubMed
- Detection and in vitro metabolism of AOD9604PubMed
Research Guide
How users approach this compound
The following reflects patterns observed in research literature and community protocols. This is not medical advice and does not constitute a clinical recommendation.
Research Protocols
Common DosagesFat Loss
“Empty stomach, ≥30 min before food”
Dosages listed are common research protocols found in peer-reviewed literature and clinical trials. Individual results and requirements may vary significantly in a research context.
Key Research Benefits
- Targets stubborn fat
- No effect on blood sugar
- Stimulates lipolysis
Potential Side Effects
Labs to monitor
Educational context only, not a testing mandate. Any bloodwork decisions belong with your clinician.
- No validated compound-specific markers: No standard bloodwork is established for this compound; general safety labs (CBC, comprehensive metabolic panel) are reasonable if used under medical supervision.
Dose Calculator
Peptide Reconstitution Calculator
Total amount of peptide in the vial.
Volume of water used to mix.
Draw to this mark
or 0.12 mL on a U-100 syringe
AOD-9604 by goal
Read AOD-9604's profile filtered through specific research goals.
Related Tools
Not medical advice
Information on DoseVault is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment from a qualified healthcare provider.